HSA
- Marketing authorisation holder: X4 PHARMS
- Status: likely_approved
🇸🇬 Xolremdi in Singapore
Xolremdi (MAVORIXAFOR) regulatory status in Singapore.
Marketing authorisation
Xolremdi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Singapore
Frequently asked questions
Is Xolremdi approved in Singapore?
Yes. HSA has authorised it.
Who is the marketing authorisation holder for Xolremdi in Singapore?
X4 PHARMS holds the Singaporean marketing authorisation.